144 related articles for article (PubMed ID: 30196107)
1. The impact of effective systemic therapies on surgery for stage IV melanoma.
Smith MJF; Smith HG; Joshi K; Gore M; Strauss DC; Hayes AJ; Larkin J
Eur J Cancer; 2018 Nov; 103():24-31. PubMed ID: 30196107
[TBL] [Abstract][Full Text] [Related]
2. Use of immunotherapy and surgery for stage IV melanoma.
Molina G; Kasumova GG; Qadan M; Boland GM
Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
[TBL] [Abstract][Full Text] [Related]
3. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
4. Role of Surgery for Metastatic Melanoma.
Enomoto LM; Levine EA; Shen P; Votanopoulos KI
Surg Clin North Am; 2020 Feb; 100(1):127-139. PubMed ID: 31753107
[TBL] [Abstract][Full Text] [Related]
5. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
[TBL] [Abstract][Full Text] [Related]
6. Role of Surgery in Combination with Immunotherapy.
Klemen ND; Shindorf ML; Sherry RM
Surg Oncol Clin N Am; 2019 Jul; 28(3):481-487. PubMed ID: 31079801
[TBL] [Abstract][Full Text] [Related]
7. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
[TBL] [Abstract][Full Text] [Related]
8. Metastasectomy for stage IV melanoma.
Deutsch GB; Kirchoff DD; Faries MB
Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
[TBL] [Abstract][Full Text] [Related]
9. Stage-IV melanoma and pulmonary metastases: factors predictive of survival.
Neuman HB; Patel A; Hanlon C; Wolchok JD; Houghton AN; Coit DG
Ann Surg Oncol; 2007 Oct; 14(10):2847-53. PubMed ID: 17680317
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment options for stage IV melanoma.
Wei IH; Healy MA; Wong SL
Surg Clin North Am; 2014 Oct; 94(5):1075-89, ix. PubMed ID: 25245969
[TBL] [Abstract][Full Text] [Related]
11. Rationale for complete metastasectomy in patients with stage IV metastatic melanoma.
Ollila DW; Gleisner AL; Hsueh EC
J Surg Oncol; 2011 Sep; 104(4):420-4. PubMed ID: 21858837
[TBL] [Abstract][Full Text] [Related]
12. Indications for the surgical resection of stage IV disease.
Bello DM
J Surg Oncol; 2019 Jan; 119(2):249-261. PubMed ID: 30561079
[TBL] [Abstract][Full Text] [Related]
13. Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck.
Babcock B; Rodrigues M; Kearns D; Solomon N; Reeves ME; Senthil M; Garberoglio CA; Namm JP
Am Surg; 2019 Oct; 85(10):1118-1124. PubMed ID: 31657306
[TBL] [Abstract][Full Text] [Related]
14. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.
Ch'ng S; Uyulmaz S; Carlino MS; Pennington TE; Shannon KF; Rtshiladze M; Stretch JR; Nieweg OE; Varey AHR; Hsiao E; Kapoor R; Pires da Silva I; Lo SN; Spillane AJ; Scolyer RA; Long GV; Hong AM; Saw RPM; Thompson JF; Menzies AM
Eur J Cancer; 2021 Aug; 153():8-15. PubMed ID: 34126335
[TBL] [Abstract][Full Text] [Related]
15. The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.
Donia M; Kimper-Karl ML; Høyer KL; Bastholt L; Schmidt H; Svane IM
Eur J Cancer; 2017 Mar; 74():89-95. PubMed ID: 28335891
[TBL] [Abstract][Full Text] [Related]
16. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
17. Role of Surgery in Stage IV Melanoma.
O'Neill CH; McMasters KM; Egger ME
Surg Oncol Clin N Am; 2020 Jul; 29(3):485-495. PubMed ID: 32482322
[TBL] [Abstract][Full Text] [Related]
18. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.
Wasif N; Bagaria SP; Ray P; Morton DL
J Surg Oncol; 2011 Aug; 104(2):111-5. PubMed ID: 21381040
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell immunotherapy for stage IV melanoma.
O'Rourke MG; Johnson MK; Lanagan CM; See JL; O'Connor LE; Slater GJ; Thomas D; Lopez JA; Martinez NR; Ellem KA; Schmidt CW
Melanoma Res; 2007 Oct; 17(5):316-22. PubMed ID: 17885587
[TBL] [Abstract][Full Text] [Related]
20. Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.
He M; Lovell J; Ng BL; Spillane J; Speakman D; Henderson MA; Shackleton M; Gyorki DE
J Surg Oncol; 2015 Jun; 111(8):980-4. PubMed ID: 26080731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
